BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/26/2024 7:20:28 AM | Browse: 40 | Download: 112
 |
Received |
|
2024-08-20 02:14 |
|
Peer-Review Started |
|
2024-08-13 14:37 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-27 02:32 |
|
Revised |
|
2024-10-01 18:58 |
|
Second Decision |
|
2024-11-01 02:37 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-11-01 06:15 |
|
Articles in Press |
|
2024-11-01 06:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-11-07 19:15 |
|
Typeset the Manuscript |
|
2024-11-11 02:29 |
|
Publish the Manuscript Online |
|
2024-11-26 07:20 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Davide Ramoni, Luca Liberale and Fabrizio Montecucco |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabrizio Montecucco, MD, PhD, Department of Internal Medicine, First Clinic of Internal Medicine, IRCCS Ospedale Policlinico San Martino, Italian Cardiovascular Network, 6 Viale Benedetto XV, Genoa 16132, Italy. fabrizio.montecucco@unige.it |
| Key Words |
Adipokines; Cardiometabolic risk assessment; Inflammatory biomarkers; Metabolic dysfunction-associated fatty liver disease; Metabolic syndrome; Osteopontin |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease is a rapidly growing condition that requires the identification of non-invasive diagnostic tools, particularly biomarkers that are readily detectable and cost-effective. In this article, we focused on inflammation-related biomarkers, which show promise due to their ability to impact both metabolic and cardiovascular diseases. Integrating these non-invasive tools into the clinical practice can reinforce risk stratification and facilitate early intervention. This approach not only enhances patient outcomes but also addresses the rising prevalence of metabolic dysfunction-associated fatty liver disease. Continued research is essential to validate these biomarkers in clinical practice and to improve the management and personalization of care strategies. |
| Publish Date |
2024-11-26 07:20 |
| Citation |
<p>Ramoni D, Liberale L, Montecucco F. Inflammatory biomarkers as cost-effective predictive tools in metabolic dysfunction-associated fatty liver disease. <i>World J Gastroenterol</i> 2024; 30(47): 5086-5091</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v30/i47/5086.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v30.i47.5086 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
